Rebecca Brachman: A new class of drug that could prevent depression and PTSD
Rebecca Brachman: Une nouvelle classe de médicaments qui pourraient prévenir la dépression et le TSPT
Rebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness. Full bio
Double-click the English transcript below to play the video.
were made from, of all things,
guerre mondiale.
one in five soldiers develop depression,
quand on voit qu'aujourd'hui,
post-traumatique ou bien des deux.
that are at high risk for these diseases.
à haut risque pour ces maladies.
cancer patients, aid workers, refugees --
les patients atteints de cancer,
les réfugiés --
or major life stress.
ou un stress majeur dans sa vie.
these disorders are,
que ces maladies soient courantes,
if they work at all,
s'ils fonctionnent,
discovered the first vaccine --
a découvert le premier vaccin --
a prophylactic for a disease,
prophylactique pour une maladie
prévenir les maladies.
to extend to psychiatric diseases.
s'étendait aux maladies psychiatriques.
accidentally discovered
avons accidentellement découvert
depression and PTSD.
prévenir la dépression et le TSPT.
whether they work in humans.
leurs effets chez les êtres humains.
psychopharmaceuticals
la résilience au stress,
stress resilience,
amplificateurs de la résilience.
that you've since recovered from.
dont vous vous êtes remis.
you missed a flight.
un examen ou un avion manqué.
is the active biological process
est un processus biologique actif
to bounce back after stress.
de rebondir après du stress.
and your immune system fights it off.
et votre système immunitaire le combat.
enough stressor,
such as depression.
tel que la dépression.
of major depressive disorder
des troubles dépressifs importants
par du stress.
against purely biological stressors,
de stress biologiques,
like bullying and isolation.
sociaux et psychologiques,
nous avons donné aux souris
of stress hormones.
d'hormones du stress.
without a psychological component.
biologique sans composante psychologique.
of antidepressant treatment beforehand,
de traitement antidépresseur,
enhancer given a week before
amplificateur de la résilience
the depressive behavior.
le comportement dépressif.
a drug has ever been shown
que l'on a montré qu'un médicament
often lifelong, clinical diseases.
sont des maladies chroniques,
of substance abuse, homelessness,
de toxicomanie, d'être sans abri,
d'Alzheimer, de suicide.
is over three trillion dollars per year.
de la dépression
de dollars par an.
where we know someone is predictively
où nous prévoyons quand quelqu'un
to extreme stress.
à un stress extrême.
going into an earthquake zone.
allant dans une zone de séisme.
of a resilience enhancer
un cachet ou une injection
de la résilience avant son départ.
by looters or worse,
de pillards ou pire,
against developing depression or PTSD
d'une dépression ou d'un TSPT
from experiencing the stress,
de ressentir le stress,
her susceptibility to depression and PTSD,
à la dépression et au TSPT,
her home, her family or even her life.
qu'il ne perde son travail,
the smallpox vaccine,
le vaccin contre la variole,
ont rapidement suivi.
was widely available.
ne soit largement disponible.
sensitive and creative and empathetic.
plus sensibles, créatives, empathiques.
by constitution and not biology.
et non biologique.
today about depression.
au sujet de la dépression.
opened the door
a ouvert la porte
that followed after,
open the possibility of a whole new field:
d'un nouveau domaine :
choose to do with it.
d'en faire en tant que société.
ABOUT THE SPEAKER
Rebecca Brachman - Neuroscientist, writer, entrepreneurRebecca Brachman is a pioneer in the field of preventative psychopharmacology, developing drugs to enhance stress resilience and prevent mental illness.
Why you should listen
Current treatments for mood disorders only suppress symptoms without addressing the underlying disease, and there are no known cures. The drugs Rebecca Brachman is developing would be the first to prevent psychiatric disorders such as post-traumatic stress disorder (PTSD) and depression.
Brachman completed her PhD at Columbia University, prior to which she was a fellow at the National Institutes of Health, where she discovered that immune cells carry a memory of psychological stress and that white blood cells can act as antidepressants and resilience-enhancers. Brachman's research has been featured in The Atlantic, WIRED and Business Insider, and her work was recently described by Dr. George Slavich on NPR as a "moonshot project that is very much needed in the mental health arena."
In addition to conducting ongoing research at Columbia, Brachman is an NYCEDC Entrepreneurship Lab Fellow and cofounder of Paravax -- a biotech startup developing vaccine-like prophylactic drugs ("paravaccines") -- along with her scientific collaborator, Christine Ann Denny. She is also working on a non-profit venture to repurpose existing generic drugs for use as prophylactics, and previously served as the Interim Program Director for Outreach at the Zuckerman Institute at Columbia University.
Brachman is also a playwright and screenwriter. She holds Bachelor's degrees in both neuroscience and creative wWriting, and she is currently working on a tech-focused writing project with her long-time writing partner, Sean Calder ("Grimm," "Damages," "ER"). She served as the director of NeuWrite, a national network of science-writing groups that fosters ongoing collaboration between scientists, writers and artists, and she has been featured as a storyteller at The Story Collider.
(Photo: Kenneth Willardt)
Rebecca Brachman | Speaker | TED.com